Featured Research

from universities, journals, and other organizations

Scientists identify molecular signals that rouse dormant HIV infection

Date:
October 30, 2013
Source:
Gladstone Institutes
Summary:
Perhaps the single greatest barrier to curbing the spread of HIV/AIDS is the dormant, or "latent," reservoir of virus, which is out of reach of even the most potent medications. But now, scientists at the Gladstone Institutes have uncovered new clues that may help researchers awaken HIV from its slumber -- laying the foundation for purging all trace of the virus, and for one day finding a cure for the more than 34 million people worldwide living with HIV/AIDS.

Research has shown that the activity level of HIV's genetic material strongly influences whether the virus remains active or whether it becomes dormant. In this image, Gladstone scientists pinpoint genetic activity (labeled in red and green) that is likely to keep HIV active. This information is being used to deepen our understanding of HIV latency.
Credit: Leor Weinberger

Perhaps the single greatest barrier to curbing the spread of HIV/AIDS is the dormant, or "latent," reservoir of virus, which is out of reach of even the most potent medications. But now, scientists at the Gladstone Institutes have uncovered new clues that may help researchers awaken HIV from its slumber -- laying the foundation for purging all trace of the virus, and for one day finding a cure for the more than 34 million people worldwide living with HIV/AIDS.

In a paper being published today in PLOS One, researchers in the laboratory of Gladstone Investigator Warner C. Greene, MD, PhD, have uncovered the molecular signals that guide the activation of latent HIV. Specifically, they showed how molecular crosstalk between calcium and an enzyme called calcineurin, along with a molecule called prostratin, switch on members of the NF-κB family of proteins -- thereby activating latent HIV. These findings point to a new strategy of artificially activating HIV -- a process that experts believe is key to flushing out all evidence of infection and developing a cure for HIV/AIDS.

During the initial stages of HIV infection, often within hours, the virus infects a type of white blood cell called CD4 T cells. In the majority of cases, HIV then hijacks the cell's DNA to produce, or "transcribe," new virus, infecting more cells. But every so often something different happens: the viral DNA inserts itself into the host cell's DNA, but then stops, maintaining a holding pattern that can persist for decades. This latent HIV is virtually undetectable and therefore cannot be targeted by medication.

"Current treatments, which involve a complex cocktail of antiretroviral (ARV) medications, are fine-tuned to target and destroy active, replicating HIV -- but they can't touch the latent virus," explained Dr. Greene, director of virology and immunology research at Gladstone and professor of medicine at the University of California, San Francisco, with which Gladstone is affiliated. "But most troublingly is that within weeks of stopping ARV treatment, the latent virus wakes up, and the cycle of replication and infection begins all over again."

What this means for patients is a lifetime of treatment with expensive ARVs. This is an unsustainable strategy in today's world, where more than two-thirds of those infected live in the developing world and have limited access to ARVs. And for every 10 people who do receive ARVs, 16 become newly infected.

Recently, researchers have championed the "shock-and-kill" strategy for combating HIV latency. This approach would activate the latent virus, and then bombard this newly active virus with ARVs. Precisely how to do so has been fraught with difficulty. But in this study, Dr. Greene and his team have identified a potential strategy.

In laboratory experiments using latent HIV introduced into CD4 cells from donors or cell culture, the research team tested a series of proteins believed to regulate activation and transcription of the virus. One such family of proteins, called NFAT, was previously shown to induce HIV transcription during the initial stages of infection. So the researchers tested whether it would also function in activating latent HIV.

"Surprisingly, NFAT didn't appear to play a central role so we went back to the drawing board, exploring other protein families we thought might be involved," said Gladstone Postdoctoral Fellow Jonathan Chan, PhD, the paper's lead author. "Interestingly, we observed that members of the NF-κB protein family appeared to act as a molecular alarm clock, rousing latent HIV and spurring viral replication."

Even more interesting was what they observed when they added prostratin to the mix. Prostratin, a naturally occurring compound that is extracted from the Samoan mamala tree, helps to activate latent HIV. But prostratin is difficult to procure and, as of right now, impossible to synthesize on an industrial scale. Now, the experiments performed by Drs. Greene and Chan suggest a potential workaround.

"When we stimulated the calcium/calcineurin pathway in the presence of low levels of prostratin, we in turn boosted prostratin's effectiveness," explained Dr. Chan. "These findings, while preliminary, hold promise that we could develop a way to purge the latent HIV reservoir with even suboptimal levels of prostratin."

"Our results give us much-needed insight how the shock-and-kill approach to eliminate the virus might work," said Dr. Greene. "Slowly but surely we are finding new components of a cure cocktail that might be able -- at long last -- to realize a broadly applicable and scaleable cure for HIV/AIDS."


Story Source:

The above story is based on materials provided by Gladstone Institutes. The original article was written by Anne Holden. Note: Materials may be edited for content and length.


Journal Reference:

  1. DebbieS. Ruelas, WarnerC. Greene. An Integrated Overview of HIV-1 Latency. Cell, 2013; 155 (3): 519 DOI: 10.1016/j.cell.2013.09.044

Cite This Page:

Gladstone Institutes. "Scientists identify molecular signals that rouse dormant HIV infection." ScienceDaily. ScienceDaily, 30 October 2013. <www.sciencedaily.com/releases/2013/10/131030185928.htm>.
Gladstone Institutes. (2013, October 30). Scientists identify molecular signals that rouse dormant HIV infection. ScienceDaily. Retrieved September 16, 2014 from www.sciencedaily.com/releases/2013/10/131030185928.htm
Gladstone Institutes. "Scientists identify molecular signals that rouse dormant HIV infection." ScienceDaily. www.sciencedaily.com/releases/2013/10/131030185928.htm (accessed September 16, 2014).

Share This



More Health & Medicine News

Tuesday, September 16, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com
Man Floats for 31 Hours in Gulf Waters

Man Floats for 31 Hours in Gulf Waters

AP (Sep. 16, 2014) A Texas man is lucky to be alive after he and three others floated for more than a day in the Gulf of Mexico when their boat sank during a fishing trip. (Sept. 16) Video provided by AP
Powered by NewsLook.com
EU Ministers and Experts Meet to Discuss Ebola Reponse

EU Ministers and Experts Meet to Discuss Ebola Reponse

AFP (Sep. 15, 2014) The European Commission met on Monday to coordinate aid that the EU can offer to African countries affected by the Ebola outbreak. Duration: 00:58 Video provided by AFP
Powered by NewsLook.com
Despite The Risks, Antibiotics Still Overprescribed For Kids

Despite The Risks, Antibiotics Still Overprescribed For Kids

Newsy (Sep. 15, 2014) A new study finds children are prescribed antibiotics twice as often as is necessary. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

      Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins